Jones Financial Companies Lllp Amgen Inc Transaction History

Jones Financial Companies Lllp

$97.4 Billion
Q3 2024

A detailed history of Jones Financial Companies Lllp transactions in Amgen Inc stock. As of the latest transaction made, Jones Financial Companies Lllp holds 18,707 shares of AMGN stock, worth $4.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,707

Previous 13,871 34.86%

Holding current value

$4.93 Million

Previous $4.33 Million 39.1%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $1.5 Million - $1.63 Million	4,836 Added 34.86%	18,707 $6.03 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $1.3 Million - $1.58 Million	4,943 Added 55.37%	13,871 $4.33 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $1.57 Million - $1.9 Million	5,844 Added 189.49%	8,928 $2.54 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $299,424 - $337,786	1,171 Added 61.21%	3,084 $888,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $54,881 - $68,136	-251 Reduced 11.6%	1,913 $514,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $82,922 - $98,054	-387 Reduced 15.17%	2,164 $480,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $6,999 - $8,531	31 Added 1.23%	2,551 $616,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $59,089 - $75,080	258 Added 11.41%	2,520 $661,000
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $69,582 - $78,476	-310 Reduced 12.05%	2,262 $510,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $5,306 - $5,905	-23 Reduced 0.89%	2,572 $626,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $23,681 - $26,197	-108 Reduced 4.0%	2,595 $628,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $40,372 - $46,202	203 Added 8.12%	2,703 $608,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $26,533 - $31,087	-125 Reduced 4.76%	2,500 $532,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $74,979 - $83,183	-321 Reduced 10.9%	2,625 $640,000
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $239,440 - $279,029	1,079 Added 57.79%	2,946 $733,000
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $218,976 - $260,762	1,012 Added 118.36%	1,867 $429,000
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $200,625 - $223,112	855 New	855 $218,000
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $211,762 - $280,855	-1,162 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $20,434 - $26,265	108 Added 10.25%	1,162 $280,000
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $183,511 - $219,885	1,054 New	1,054 $204,000
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $432,821 - $487,884	-2,393 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $426,911 - $498,342	2,393 New	2,393 $466,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.

Account

Jones Financial Companies Lllp Amgen Inc Transaction History